Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ambroxol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 65Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    India prohibits use of propylene glycol from supplier linked to Uzbekistan deaths
    India prohibits use of propylene glycol from supplier linked to Uzbekistan deaths

    10 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/india-prohibits-use-of-propylene-glycol-from-supplier-linked-to-uzbekistan-deaths/articleshow/98518581.cms

    ECONOMIC TIMES
    10 Mar 2023
    Share Share
    EC Confirms Use of Ambroxol and Bromhexine APIs
    EC Confirms Use of Ambroxol and Bromhexine APIs

    26 Jan 2016

    // DCAT CONNECT

    http://connect.dcat.org/blogs/pharma-news/2016/01/26/ec-confirms-use-of#.VqhfhJp97IU

    DCAT CONNECT
    26 Jan 2016
    Share Share
    Ambroxol and Bromhexine Expectorants: Safety Information to Be Updated
    Ambroxol and Bromhexine Expectorants: Safety Information to Be Updated

    28 Feb 2015

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/02/news_detail_002276.jsp&mid=WC0b01ac058004d5c1

    EMA
    28 Feb 2015
    Share Share
    PRAC Considers Risk of Severe Allergic Reactions with Ambroxol and Bromhexine-Containing Medicines to be Small
    PRAC Considers Risk of Severe Allergic Reactions with Ambroxol and Bromhexine-Containing Medicines to be Small

    12 Jan 2015

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002248.jsp&mid=WC0b01ac058004d5c1

    EMA
    12 Jan 2015
    Share Share